Mayne Pharma Ltd (ASX: MYX) is an Australian specialist pharmaceutical company, creating commericialised and generic products you’ll find in pharmacies across Australia. Mayne Pharma’s history started in South Australia. Today, it develops most of its drugs in Australia and the USA.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.17% at lunch.
The Mayne Pharma Group Ltd (ASX:MYX) share price went up 10.5% after it released its FY19 result today.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 1.14% at lunch.
The Mayne Pharma Group Ltd (ASX:MYX) share price is down 15% in early trade after giving a trading update.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.38% at lunch.
Mayne Pharma Group Ltd (ASX:MYX) reported half year earnings this morning for the period ended 31st December 2018.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX: XAO), is currently up 0.16% at lunch.
The Mayne Pharma Group Ltd (ASX:MYX) share price is up 1.2% with the company announcing the launch of the TOLSURA 65mg capsule in the US.
The S&P/ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) went down 0.15.% on Tuesday.
